SNHG5 and chronic myelogenous leukemia, BCR-ABL1 positive: In a recent experiment by Baoming et al., the expression pattern of SNHG5 and ABCC2 were evaluated in CML patients to understand the probable associations between these factors and development of imatinib-resistance [24].